Behcet's Syndrome

被引：0
|
作者：
Xenitidis, Theodoros [1 ]
Henes, Joerg Christoph [1 ]
机构：
[1] Univ Klinikum Tubingen, Med Univ Klin, Abt & Lehrstuhl 2, Hamatol Onkol Klin Immunol Rheumatol, Tubingen, Germany
来源：
AKTUELLE RHEUMATOLOGIE | 2019年 / 44卷 / 04期
关键词：
Vasculitis; Review; Therapy; Behcet's syndrome; PULMONARY-ARTERY INVOLVEMENT; INTERFERON ALPHA-2A; DOUBLE-BLIND; GASTROINTESTINAL MANIFESTATIONS; CLINICAL-FEATURES; NERVOUS-SYSTEM; DISEASE; COLCHICINE; UVEITIS; PREVALENCE;
D O I：
10.1055/a-0979-4510
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Behcet's syndrome (BS) is classified as a variable vessel vasculitis. The clinical picture is very diverse and usually requires interdisciplinary collaboration. Pathogenetically, BS seems to take a middle position between a polygenic autoinflammatory disease and an autoimmune disease. New EULAR recommendations were issued in 2018. The therapy depends on which organs are most affected. Since 2016, adalimumab has been approved for the treatment of posterior ocular involvement. Infliximab, interferon a2a, interleukin-1 antagonists and apremilast may be alternative therapies.
引用
收藏
页码：262 / 275
页数：14
相关论文
共 50 条
  • [41] Epidemiology of Behcet's syndrome in Turkey
    Tuzun, Y
    Yurdakul, S
    Ozyazgan, Y
    Hamuryudan, V
    Tuzun, B
    Yazici, H
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1996, 35 (09) : 618 - 620
  • [42] Behcet's syndrome (BS): an update
    Yazici, Hasan
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 730 - 730
  • [43] Behcet's syndrome: Facts and controversies
    Mat, Cem
    Yurdakul, Sebahattin
    Sevim, Aysegul
    Ozyazgan, Yilmaz
    Tuzun, Yalcin
    CLINICS IN DERMATOLOGY, 2013, 31 (04) : 352 - 361
  • [44] Update on the treatment of Behcet's syndrome
    Esatoglu, Sinem Nihal
    Hatemi, Gulen
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (05) : 661 - 675
  • [45] Behcet's syndrome is not associated with vitiligo
    Oran, M.
    Yazici, H.
    Hatemi, G.
    Tasli, L.
    Garip, F.
    Kadioglu, P.
    Mat, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 370 - 370
  • [46] Wound healing in Behcet's syndrome
    Mat, MC
    Nazarbaghi, M
    Tuzun, Y
    Hamuryudan, V
    Hizli, N
    Yurdakul, S
    Ozyazgan, Y
    Yazici, H
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1998, 37 (02) : 120 - 123
  • [47] Empiricism in managing Behcet's syndrome
    Yazici, H.
    Hatemi, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) : S7 - S9
  • [48] A reappraisal of amyloidosis in Behcet's syndrome
    Melikoglu, M
    Altiparmak, MR
    Fresko, I
    Tunç, R
    Yurdakul, S
    Hamuryudan, V
    Yazici, H
    RHEUMATOLOGY, 2001, 40 (02) : 212 - 215
  • [49] Neurological complications in Behcet's syndrome
    Kidd, D
    Steuer, A
    Denman, AM
    Rudge, P
    BRAIN, 1999, 122 : 2183 - 2194
  • [50] Venous Thrombosis in Behcet's Syndrome
    Kanji, Tahir
    Clements-Baker, Marie
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1062 - 1062
12345